|
🐜
|
Platinum-based chemotherapy plus cetuximab in head and neck cancer.
18 auth.
J. Vermorken,
R. Mesía,
F. Rivera,
É. Remenár,
A. Kawecki,
S. Rottey,
J. Erfán,
D. Zabolotnyy,
H. Kienzer,
D. Cupissol,
...
F. Peyrade,
M. Benasso,
I. Vynnychenko,
D. de Raucourt,
C. Bokemeyer,
A. Schueler,
N. Amellal,
R. Hitt
|
11 |
2008 |
11
🐜
|
|
🐜
|
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
18 auth.
J. Vermorken,
J. Stöhlmacher-Williams,
I. Davidenko,
L. Licitra,
E. Winquist,
C. Villanueva,
P. Foa,
S. Rottey,
K. Składowski,
M. Tahara,
...
V. Pai,
S. Faivre,
C. Blajman,
A. Forastiere,
B. Stein,
K. Oliner,
Zhiying Pan,
B. Bach
|
8 |
2013 |
8
🐜
|
|
🐜
|
Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial
20 auth.
A. Bex,
P. Mulders,
M. Jewett,
J. Wagstaff,
J. V. Thienen,
C. Blank,
R.C.E. van Velthoven,
M. P. Laguna,
L. Wood,
H. Melick,
...
M. Aarts,
J. Lattouf,
T. Powles,
I. D. Jong,
S. Rottey,
B. Tombal,
S. Marréaud,
S. Collette,
L. Collette,
J. Haanen
|
8 |
2019 |
8
🐜
|
|
🐜
|
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study.
17 auth.
U. Banerji,
C. V. van Herpen,
C. Saura,
F. Thistlethwaite,
S. Lord,
V. Moreno,
I. Macpherson,
V. Boni,
C. Rolfo,
E. D. de Vries,
...
S. Rottey,
J. Geenen,
F. Eskens,
M. Gil-Martin,
E. Mommers,
N. Koper,
P. Aftimos
|
8 |
2019 |
8
🐜
|
|
🐜
|
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma.
12 auth.
Thomas E. Hutson,
I. Davis,
J. Machiels,
P. de Souza,
S. Rottey,
B. Hong,
...
R. Epstein,
K. Baker,
L. McCann,
T. Crofts,
L. Pandite,
R. Figlin
|
8 |
2010 |
8
🐜
|
|
🐜
|
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study
14 auth.
L. Licitra,
R. Mesía,
F. Rivera,
É. Remenár,
R. Hitt,
J. Erfán,
S. Rottey,
A. Kawecki,
D. Zabolotnyy,
M. Benasso,
...
S. Störkel,
S. Senger,
C. Stroh,
J. Vermorken
|
7 |
2010 |
7
🐜
|
|
🐜
|
Cyclooxygenase-2 as a target for anticancer drug development.
7 auth.
J. Méric,
S. Rottey,
K. Olaussen,
J. Soria,
D. Khayat,
O. Rixe,
...
J. Spano
|
7 |
2006 |
7
🐜
|
|
🐜
|
CD70: An emerging target in cancer immunotherapy.
9 auth.
J. Jacobs,
V. Deschoolmeester,
K. Zwaenepoel,
C. Rolfo,
K. Silence,
S. Rottey,
...
F. Lardon,
E. Smits,
P. Pauwels
|
7 |
2015 |
7
🐜
|
|
🐜
|
Distant metastases in head and neck cancer
9 auth.
F. Duprez,
D. Berwouts,
W. Neve,
K. Bonte,
T. Boterberg,
P. Deron,
...
W. Huvenne,
S. Rottey,
M. Mareel
|
7 |
2017 |
7
🐜
|
|
🐜
|
Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma.
17 auth.
N. Sundahl,
G. Vandekerkhove,
K. Decaestecker,
Annabel Meireson,
P. D. De Visschere,
V. Fonteyne,
D. De Maeseneer,
D. Reynders,
E. Goetghebeur,
J. van Dorpe,
...
S. Verbeke,
M. Annala,
L. Brochez,
K. Van der Eecken,
A. Wyatt,
S. Rottey,
P. Ost
|
6 |
2019 |
6
🐜
|
|
🐜
|
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial
43 auth.
Jozefien Declercq,
Karel F. A. Van Damme,
E. De Leeuw,
B. Maes,
C. Bosteels,
S. Tavernier,
Stefanie De Buyser,
R. Colman,
M. Hites,
Gil Verschelden,
T. Fivez,
F. Moerman,
I. Demedts,
N. Dauby,
Nicolas de Schryver,
...
Elke Govaerts,
S. Vandecasteele,
J. Van Laethem,
S. Anguille,
J. V. D. van der Hilst,
B. Misset,
H. Slabbynck,
X. Wittebole,
F. Lienart,
C. Legrand,
M. Buyse,
D. Stevens,
F. Bauters,
Leen Seys,
H. Aegerter,
U. Smole,
Victor Bosteels,
L. Hoste,
L. Naesens,
F. Haerynck,
L. Vandekerckhove,
P. Depuydt,
E. Van Braeckel,
S. Rottey,
I. Peene,
C. Van Der Straeten,
F. Hulstaert,
B. Lambrecht
|
6 |
2021 |
6
🐜
|
|
🐬
|
Glycosylation of prostate specific antigen and its potential diagnostic applications.
T. Vermassen,
M. Speeckaert,
N. Lumen,
S. Rottey,
J. Delanghe
|
6 |
2012 |
6
🐬
|
